Thromb Haemost 1976; 35(02): 377-381
DOI: 10.1055/s-0038-1647931
Original Article
Schattauer GmbH

Treatment of Amyloidosis Associated Factor X Deficiency

Joel A. Spero
1   Department of Medicine, University of Pittsburgh and Central Blood Bank of Pittsburgh, Pittsburgh PA 15219
,
Jessica H. Lewis
1   Department of Medicine, University of Pittsburgh and Central Blood Bank of Pittsburgh, Pittsburgh PA 15219
,
Ute Hasiba
1   Department of Medicine, University of Pittsburgh and Central Blood Bank of Pittsburgh, Pittsburgh PA 15219
,
Lawrence D. Ellis
1   Department of Medicine, University of Pittsburgh and Central Blood Bank of Pittsburgh, Pittsburgh PA 15219
› Author Affiliations
Further Information

Publication History

Received 02 October 1975

Accepted 20 November 1975

Publication Date:
02 July 2018 (online)

Summary

This is the tenth patient in thirteen years to be reported with the findings of an isolated factor X deficiency associated with primary amyloidosis. A favorable response to factor IX concentrate was manifested by temporary clinical and laboratory correction of her diathesis. This mode of treatment, therefore, provides an approach to therapy for bleeding complications in this group of patients who have previously failed to respond to fresh frozen plasma.

 
  • References

  • 1 André R, Duhamel G, Vergoz D, Rochant D. 1966; Syndrome hémorragique par deficit acquis en facteur Stuart-Prower. Amylose. Maladie de Waldenstrom. Bulletins et Memoirs de la Société Médicale des Hôpitaux de Paris 117: 41.
  • 2 Bayer W. L, Curiel D, Szeto I. L. F, Lewis J. H. 1969; Acquired factor X deficiency in a negro boy. Pediatrics 44: 1007.
  • 3 Bernhardt B, Valletta M, Brook J, Lejnieks I. 1972; Case report. Amyloidosis with factor X deficiency. American Journal of Medical Sciences 264: 411.
  • 4 Galbraith P. A, Sharma N, Parker W. L, Kilgour J. M. 1974; Acquired factor X deficiency. Altered plasma anti-thrombin activity and association with amyloidosis. Journal of the American Medical Association 230: 1658.
  • 5 Howell M. 1963; Acquired factor X deficiency associated with systematized amyloidosis: report of a case. Blood 21: 739.
  • 6 Jacobsen R. J, Sandler S. G, Rath C. E. 1972; Systemic amyloidosis associated with microangiopathic haemolytic anemia and factor X (Stuart) deficiency. South African Medical Journal 46: 1634.
  • 7 Korsan-Bengsten K, Hjort P. F, Ygge J. 1962; Acquired factor X deficiency in a patient with amyloidosis. Tlirombosis Diathesis Haemorrhagica 7: 588.
  • 8 Lewis J. H, Wilson J. H, Brandon J. M. 1972; Counterelectrophoresis test for molecules immunologically similar to fibrinogen. American Journal of Clinical Pathology 58: 405.
  • 9 Ménaché D, Boivin P. 1962; Deficit acquis en facteur X chez un malade atteint d’amylose primitive. Injection d’une fraction C.S.B. Nouvelle Revue Française d’Hématologie (Paris) 2: 868.
  • 10 O’Lear y D. S, Ruymann F. B, Conrad M. E. 1971; Therapeutic approaches to factor X deficiency with emphasis on the use of a new clotting factor concentrate (Konyne). Journal of Laboratory and Clinical Medicine 77: 23.
  • 11 Ottolander G. J, Perret L. J. 1965; Verworken hemorragische diathese ten gevolge van geisoleerde factor X deficentie. Nederlands Tijdschrift voor Geneesckunde (Amsterdam) 109: 852.
  • 12 Pechet L, Kastrul J. J. 1964; Amyloidosis associated with factor X (Stuart) deficiency. Annals of Internal Medicine 61: 315.